Dr. Reddy's brings generic Levaquin to market

HYDERABAD, India — Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.

The company said its levofloxacin tablets in the 250-mg, 500-mg and 750-mg strengths have entered the market, following the Food and Drug Administration's approval of Dr. Reddy's abbreviated new drug application. Dr. Reddy's levofloxacin tablets in the 250-mg and 500-mg strengths are available in 50-count bottles, while the 750-mg strength bottle is available in 30-count bottles.

Levofloxacin tablets are a generic version of Levaquin, an Ortho-McNeil-Janssen Pharmaceuticals drug. The FDA earlier this week approved several generic versions of Levaquin in tablet, oral solution and injectable solution dosage forms.

U.S. sales of Levaquin totaled approximately $1.1 billion for the 12 months ended in March, according to IMS Health data.